Computable Genomix qPCR

Bioinformatic GeneIndexer latent semantic indexing (LSI) plasmids

computablegenomix
Ae1 Ae3 Antibody Antibodies Assay Kits Bafilomycin A1 Bile Acid Assay Biology Cells Canine Albumin cDNA Choline Acetyltransferase Antibody Clia Kits Culture Cells Deoxycholic Acid Sodium Salt Devices DNA DNA Templates DNA Testing Enzymes Equipments Exosomes F Actin Antibody Fto Antibody Gels Glycodeoxycholic Acid Gsk3 Alpha Hama Antibodies Hdac Activity Assay Isotypes Laminin Alpha 5 Medium & Serums Mip 1B Mmp Activity Assay Mothers Against Decapentaplegic Mouse Albumin Elisa Panel Particles PCR Pcr Kits Peptides Phospho 4Ebp1 Primary Antibodies Reagents Recombinant Proteins Ria Kits Secreted Alkaline Phosphatase Soft Agar Tgf Alpha Antibody Tgf Alpha Elisa Trypsin Activity Assay Tubastatin A Uric Acid Assay Valproic Acid Sodium Salt Vi Alpha

Platinum chloride-based viability RT-qPCR for SARS-CoV-2 detection in complex samples

Isolation, contact tracing and restrictions on social motion are being globally carried out to stop and management onward unfold of SARS-CoV-2, though the an infection threat modelled on RNA detection by RT-qPCR stays biased as viral shedding and infectivity will not be discerned.
Thus, we aimed to develop a speedy viability RT-qPCR process to deduce SARS-CoV-2 infectivity in scientific specimens and environmental samples. We screened monoazide dyes and platinum compounds as viability molecular markers on 5 SARS-CoV-2 RNA targets. A platinum chloride-based viability RT-qPCR was then optimized utilizing genomic RNA, and inactivated SARS-CoV-2 particles inoculated in buffer, stool, and urine.
Our outcomes had been lastly validated in nasopharyngeal swabs from individuals who examined constructive for COVID-19 and in wastewater samples constructive for SARS-CoV-2 RNA. We established a speedy viability RT-qPCR that selectively detects doubtlessly infectious SARS-CoV-2 particles in advanced matrices. Particularly, the confirmed positivity of nasopharyngeal swabs following the viability process suggests their potential infectivity, whereas the whole prevention of amplification in wastewater indicated both non-infectious particles or free RNA.
The viability RT-qPCR strategy supplies a extra correct ascertainment of the infectious viruses detection and it could complement analyses to foster risk-based investigations for the prevention and management of recent or re-occurring outbreaks with a broad software spectrum.

 

Utility of Repeat Nasopharyngeal SARS-CoV-2 RT-PCR Testing and Refinement of Diagnostic Stewardship Strategies at a Tertiary Care Tutorial Center in a Low-Prevalence Area of america

Background: Numerous parts have led to a very extreme amount of maximum acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription polymerase chain response (RT-PCR) testing. Concerns exist about sensitivity and false-negative SARS-CoV-2 RT-PCR testing outcomes. We describe a retrospective observational analysis inspecting the utility of repeat nasopharyngeal (NP) SARS-CoV-2 RT-PCR testing at a tutorial coronary heart in a low-prevalence setting.

 

Methods: All victims inside our nicely being system with >1 NP SARS-CoV-2 RT-PCR test end result have been included. SARS-CoV-2 RT-PCR testing was carried out primarily based on 1 of 4 validated assays. Key scientific and demographic data have been collected, along with whether or not or not the affected particular person was inpatient or outpatient at time of the test and whether or not or not the test was carried out as part of a person beneath investigation (PUI) for potential coronavirus sickness 2019 or for asymptomatic screening.

 

Outcomes: A whole of 660 victims had >1 NP SARS-CoV-2 PCR test carried out. The preliminary test was unfavourable in 638. There have been solely 6 negative-to-positive conversions (0.9%). All 6 have been outpatients current course of a PUI workup 5-17 days after an preliminary unfavourable end result. In >260 inpatients with repeat testing, we found no instances of negative-to-positive conversion along with these current course of PUI or asymptomatic evaluation.

 

Conclusions: In a low-prevalence house, repeat inpatient testing after an preliminary unfavourable end result, using a extraordinarily analytically delicate SARS-CoV-2 RT-PCR, did not present negative-to-positive conversion. The scientific sensitivity of NP RT-PCR testing is also larger than beforehand believed. These outcomes have helped type diagnostic stewardship pointers, notably steering to decrease repeated testing inside the inpatient setting to optimize test utilization and defend belongings.

computablegenomix
computablegenomix

Enchancment of a real-time PCR assay for detection and quantification of Streptococcus iniae using the lactate permease gene

 

The aim of this analysis is the occasion and evaluation of a quick and proper quantitative PCR (qPCR)-based protocol for detection of zoonotic pathogen Streptococcus iniae in bacterial cultures and tissues of diseased fish. For this aim, the lactate permease-encoding (lldY) gene was chosen as a aim for the design of S. iniae-specific primers based on comparative genomic analysis using 45 sequences retrieved from NCBI genome database. Specificity and applicability of these primers have been examined using 115 bacterial strains and fish tissues contaminated with S. iniae.

 

Sensitivity, reproducibility and effectivity of qPCR assay have been moreover determined. The developed qPCR assay confirmed 100% specificity with pure bacterial cultures or DNA extracted from S. iniae or tissues of fish contaminated with the bacterium. The technique has extreme sensitivity with a detection prohibit of 1.12 × 101 amplicon copies per assay (equal to 2 × 10-9 ng/µl) using bacterial DNA and of 1.44 × 101 gene copies in tissues of fish contaminated with S. iniae. In conclusion, this qPCR protocol provides an right and delicate numerous for the identification of S. iniae and its detection on fish tissues which may be carried out as a routine instrument in microbiological laboratories.

 

Enchancment of a New Multiplex Precise Time RT-PCR Assay for SARS-CoV-2 Detection

 

 

We describe the occasion of a model new multiplex precise time reverse transcription (RT)-PCR test for detection of SARS-CoV-2, with primers designed to amplify a 108 bp aim on the spike flooring glycoprotein (S gene) and a hydrolysis Taqman probe designed to notably detect SARS-CoV-2. We then evaluated the prohibit of detection (LOD) and scientific effectivity of this new assay. A LOD analysis with inactivated virus exhibited equal effectivity to the modified CDC assay with a closing LOD of 1,301 ± 13 genome equivalents/ml for the Northwell Nicely being Laboratories laboratory developed test (NWHL LDT) vs. 1,249 ± 14 genome equivalents/ml for the modified CDC assay.

 

Furthermore, a scientific evaluation with 270 nasopharyngeal (NP) swab specimens exhibited 98.5% optimistic % settlement and 99.3% unfavourable % settlement compared with the modified CDC assay. The NWHL LDT multiplex design permits testing of 91 victims per plate, versus a most of 29 victims per plate on the modified CDC assay, providing the benefit of testing significantly additional victims per run and saving reagents, all through a time when every of these parameters are essential.

 

The outcomes present that the NWHL LDT multiplex assay performs along with the modified CDC assay, nevertheless is additional surroundings pleasant and worth environment friendly and may be utilized as a diagnostic assay and for epidemiological surveillance and scientific administration of SARS-CoV-2.

 

GPR160 Antibody

E047605 100μg/100μl
EUR 255
Description: Available in various conjugation types.

GPR160 Antibody

E11-140G 100μg
EUR 225
Description: Available in various conjugation types.

GPR160 Antibody

E19-4899 100μg/100μl
EUR 225
Description: Available in various conjugation types.

GPR160 Antibody

DF4899 200ul
EUR 420

GPR160 Antibody

DF4899-100ul 100ul
EUR 280

GPR160 Antibody

DF4899-200ul 200ul
EUR 350

GPR160 antibody

70R-31407 100 ug
EUR 294
Description: Rabbit polyclonal GPR160 antibody

GPR160 antibody

70R-50939 100 ul
EUR 242
Description: Purified Polyclonal GPR160 antibody

GPR160 Antibody

1-CSB-PA008825
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against GPR160. Recognizes GPR160 from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/10000

GPR160 Antibody

ABD4899 100ug
EUR 325

GPR160 Antibody

MBS7119398-005mg 0.05mg
EUR 150

GPR160 Antibody

MBS7119398-01mg 0.1mg
EUR 190

GPR160 Antibody

MBS7119398-5x01mg 5x0.1mg
EUR 845

GPR160 Antibody

MBS9232645-01mL 0.1mL
EUR 415

GPR160 Antibody

MBS9232645-5x01mL 5x0.1mL
EUR 1841

GPR160 Antibody

MBS8515601-01mg 0.1mg
EUR 305

GPR160 Antibody

MBS8515601-01mLAF405L 0.1mL(AF405L)
EUR 465

GPR160 Antibody

MBS8515601-01mLAF405S 0.1mL(AF405S)
EUR 465

GPR160 Antibody

MBS8515601-01mLAF610 0.1mL(AF610)
EUR 465

GPR160 Antibody

MBS8515601-01mLAF635 0.1mL(AF635)
EUR 465

GPR160 Antibody

MBS853183-01mg 0.1mg
EUR 305

GPR160 Antibody

MBS853183-01mLAF405L 0.1mL(AF405L)
EUR 465

GPR160 Antibody

MBS853183-01mLAF405S 0.1mL(AF405S)
EUR 465

GPR160 Antibody

MBS853183-01mLAF610 0.1mL(AF610)
EUR 465

GPR160 Antibody

MBS853183-01mLAF635 0.1mL(AF635)
EUR 465

GPR160 Antibody

MBS5315557-01mL 0.1mL
EUR 470

GPR160 Antibody

MBS5315557-5x01mL 5x0.1mL
EUR 1955

GPR160 antibody

MBS535434-005mg 0.05mg
EUR 1125

GPR160 antibody

MBS535434-5x005mg 5x0.05mg
EUR 4905

GPR160 Antibody

MBS9606351-01mL 0.1mL
EUR 260

GPR160 Antibody

MBS9606351-02mL 0.2mL
EUR 305

GPR160 Antibody

MBS9606351-5x02mL 5x0.2mL
EUR 1220

GPR160 Antibody

MBS9430587-01mL 0.1mL
EUR 305

GPR160 Antibody

MBS9430587-5x01mL 5x0.1mL
EUR 1230

GPR160 Antibody

MBS9507949-005mL 0.05mL
EUR 285

GPR160 Antibody

MBS9507949-01mL 0.1mL
EUR 385

GPR160 Antibody

MBS9507949-5x01mL 5x0.1mL
EUR 1590

GPR160 Antibody

MBS9509528-005mL 0.05mL
EUR 285

GPR160 Antibody

MBS9509528-01mL 0.1mL
EUR 385

GPR160 Antibody

MBS9509528-5x01mL 5x0.1mL
EUR 1590

GPR160 Antibody

G140-100ul 100μl
EUR 217
Description: GPR160 Rabbit Polyclonal Antibody

GPR160 Antibody

G140-50ul 50μl
EUR 143.5
Description: GPR160 Rabbit Polyclonal Antibody

GPR160 Polyclonal Antibody

ABP54526-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of GPR160 from Human. This GPR160 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR160 at AA rangle: 270-350

GPR160 Polyclonal Antibody

ABP54526-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of GPR160 from Human. This GPR160 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR160 at AA rangle: 270-350

GPR160 Polyclonal Antibody

ABP54526-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of GPR160 from Human. This GPR160 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR160 at AA rangle: 270-350

GPR160 Polyclonal Antibody

E20-71990 100ug
EUR 225
Description: Available in various conjugation types.

GPR160 Conjugated Antibody

C47605 100ul
EUR 476.4

GPR160 Polyclonal Antibody

E-AB-19949-120uL 120uL
EUR 240
Description: Unconjugated

GPR160 Polyclonal Antibody

E-AB-19949-200uL 200uL
EUR 399
Description: Unconjugated

GPR160 Polyclonal Antibody

E-AB-19949-20uL 20uL
EUR 73
Description: Unconjugated

GPR160 Polyclonal Antibody

E-AB-19949-60uL 60uL
EUR 143
Description: Unconjugated

GPR160 Polyclonal Antibody

BT-AP03712-100ul 100ul Ask for price
Description: Orphan receptor.

GPR160 Polyclonal Antibody

BT-AP03712-20ul 20ul Ask for price
Description: Orphan receptor.

GPR160 Polyclonal Antibody

BT-AP03712-50ul 50ul Ask for price
Description: Orphan receptor.

GPR160 Polyclonal Antibody

E44H04883 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

GPR160 Polyclonal Antibody

MBS8522971-01mg 0.1mg
EUR 305

GPR160 Polyclonal Antibody

MBS8522971-01mLAF405L 0.1mL(AF405L)
EUR 465

GPR160 Polyclonal Antibody

MBS8522971-01mLAF405S 0.1mL(AF405S)
EUR 465

GPR160 Polyclonal Antibody

MBS8522971-01mLAF610 0.1mL(AF610)
EUR 465

GPR160 Polyclonal Antibody

MBS8522971-01mLAF635 0.1mL(AF635)
EUR 465

GPR160 Polyclonal Antibody

MBS2561838-002mL 0.02mL
EUR 135

GPR160 Polyclonal Antibody

MBS2561838-006mL 0.06mL
EUR 190

GPR160 Polyclonal Antibody

MBS2561838-012mL 0.12mL
EUR 265

GPR160 Polyclonal Antibody

MBS2561838-02mL 0.2mL
EUR 415

GPR160 Polyclonal Antibody

MBS2561838-5x02mL 5x0.2mL
EUR 1835

GPR160 Conjugated Antibody

MBS9455452-01mLAF350 0.1mL(AF350)
EUR 480

GPR160 Conjugated Antibody

MBS9455452-01mLAF405 0.1mL(AF405)
EUR 480

GPR160 Conjugated Antibody

MBS9455452-01mLAF488 0.1mL(AF488)
EUR 480

GPR160 Conjugated Antibody

MBS9455452-01mLAF555 0.1mL(AF555)
EUR 480

GPR160 Conjugated Antibody

MBS9455452-01mLBiotin 0.1mL(Biotin)
EUR 480

GPR160 Polyclonal Antibody

RD219949A-120uL 120μL
EUR 360
Description: Orphan receptor.

GPR160 Polyclonal Antibody

RD219949A-200uL 200μL
EUR 630
Description: Orphan receptor.

GPR160 Polyclonal Antibody

RD219949A-20uL 20μL
EUR 109.5
Description: Orphan receptor.

GPR160 Polyclonal Antibody

RD219949A-60uL 60μL
EUR 214.5
Description: Orphan receptor.

GPR160 Antibody (C-term)

MBS9213578-008mL 0.08mL
EUR 210

GPR160 Antibody (C-term)

MBS9213578-04mL 0.4mL
EUR 430

GPR160 Antibody (C-term)

MBS9213578-5x04mL 5x0.4mL
EUR 1910

Polyclonal GPR160 Antibody (Internal)

APR16513G 0.05ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR160 (Internal). This antibody is tested and proven to work in the following applications:

GPR160 Rabbit Polyclonal Antibody

ES5525-100ul 100ul
EUR 124
Description: A Rabbit Polyclonal antibody against GPR160 from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

GPR160 Rabbit Polyclonal Antibody

ES5525-50ul 50ul
EUR 74
Description: A Rabbit Polyclonal antibody against GPR160 from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

GPR160 Rabbit Polyclonal Antibody

E10G13515 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

GPR160 Rabbit Polyclonal Antibody

E10G06629 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

GPR160 Antibody - C-terminal region

MBS3217022-01mL 0.1mL
EUR 455

GPR160 Antibody - C-terminal region

MBS3217022-5x01mL 5x0.1mL
EUR 1995

GPR160 Antibody - N-terminal region

MBS3217023-01mL 0.1mL
EUR 455

GPR160 Antibody - N-terminal region

MBS3217023-5x01mL 5x0.1mL
EUR 1995

Polyclonal GPR160 Antibody (Extracellular Domain)

APR16512G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR160 (Extracellular Domain). This antibody is tested and proven to work in the following applications:

Anti- G Protein-Coupled Receptor GPR160/GPCR150 Human Antibody

GWB-84AB9F 0.05 mg Ask for price

GPR160 Antibody (C-term) Blocking Peptide

MBS9228244-INQUIRE INQUIRE Ask for price

Polyclonal GPR160 Antibody - C-terminal region

APR16514G 0.05mg
EUR 633.6
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR160 - C-terminal region. This antibody is tested and proven to work in the following applications:
Christopher Miller

Tags:
computablegenomix
computablegenomix